WallStreetZenWallStreetZen

How to Buy Effector Therapeutics Stock

Effector Therapeutics Inc

eFFECTOR Therapeutics, Inc. , a clinical-stage biopharmaceutical company, engages in the development of selective translation regulator inhibitors for the treatment of cancer.

Effector Therapeutics stock last closed at $1.78, down 5.82% from the previous day, and has decreased 82.19% in one year. It has underperformed other stocks in the Biotechnology industry by 0.56 percentage points. Effector Therapeutics stock is currently +1.71% from its 52-week low of $1.75, and -95.19% from its 52-week high of $37.00.

There are currently 3.69M EFTR shares outstanding. The market cap of EFTR is $6.56M. In the last 24 hours, 143,015 EFTR shares were traded.

How to Buy Effector Therapeutics Stock

Wondering how to invest in Effector Therapeutics stock? Here's how.
  1. Choose where to buy Effector Therapeutics stock: You need to pick a stock brokerage, but don't worry - we've tried dozens of online brokerages and apps to help you figure out where to buy Effector Therapeutics stock.
  2. Open a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've found.
  3. Deposit money your brokerage account: Choose your method of payment and add your info.
  4. Analyze Effector Therapeutics stock: The Effector Therapeutics ticker symbol is EFTR. Is Effector Therapeutics stock a good investment? Should you buy shares of EFTR? How do EFTR's underlying business fundamentals look? Do top analysts think Effector Therapeutics is a good buy? Why has EFTR's stock price moved recently? (Hint: Our stock research website can help you figure out if EFTR is a good stock to buy).
  5. Place your EFTR trade: Decide if you will purchase EFTR shares at the current market price or use a limit order to buy EFTR stock at a given price.
  6. Watch your EFTR position: Create a watchlist to keep tabs on your position in Effector Therapeutics shares.

Step 1: Choose where to buy Effector Therapeutics stock

You will need an online brokerage account in order to access the NASDAQ market and buy EFTR shares.

A brokerage account enables you to buy and sell a variety of financial instruments, including stocks, bonds, mutual funds, and ETFs.

Our favorite brokerage: eToro

We believe that eToro is the best online stock brokerage. Here's why:

  • You can invest in stocks with zero commissions: Invest without paying trading commissions.
  • Buy fractional shares: Even if you don't have the money to buy a full share, you can still purchase the stock.
  • Access to global financial markets: From Tech to Industrials, New York to Shanghai — you can fill your portfolio with stocks from the globe's top exchanges.
  • Social investing: eToro offers a community of more than 20 million users globally. Talk to, learn from, and copy the crypto trades of other investors.
  • Security: eToro is a regulated and licensed fintech leader.
  • Buy other assets: Such as ETFs and cryptos.

Get $10 towards your purchase of shares by creating an account with eToro today.

Open eToro Account
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.

Step 2: Open a brokerage account

Now that you've chosen the right brokerage, it's time to fill out some personal info so you can buy EFTR today.

How to Start a New Investment Account on eToro

  1. Click here to get started.
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
  2. Provide your personal data to start a new trading account.
  1. Submit your application by hitting the "Create Account" button.
  2. Get started with eToro today
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 3: Deposit money your brokerage account

Now that you've filled out your info on the highest rated app to buy and sell stocks, you need to deposit funds:

Watch this video walkthrough to see the process of depositing funds into your investment account.

Get started with eToro today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 4: Analyze Effector Therapeutics stock

After you have decided on the best place to buy Effector Therapeutics stock, it's important to research their stock prior to buying, so you truly comprehend the risk as well as the opportunity.

Effector Therapeutics Numbers

EFTR Price
$1.78
1w %
-20.36%
1y %
-82.19%
5y %
N/A
P/E
-0.11x
P/B
-1.13x
P/S
N/A
PEG
N/A
Revenue
$0.00
Earnings
-$35.81M
Fore. Rev. Growth
N/A
Fore. Earn. Growth
N/A
Market Cap
$6.56M
Next Earnings
May 7, 2024
Next Dividend
N/A

Effector Therapeutics Overview

WallStreetZen was designed to help everyday investors perform more accurate fundamental analysis in less time.

You can view all of the due diligence checks on EFTR's stock page.

How is EFTR stock valued?

Investors use a variety of different financial metrics, analyses, models, and charts to gauge EFTR's true value.

You can do additional valuation analysis on EFTR's stock here.

EFTR Financial Summary

Positive Financial Indicators:

  • EFTR has $18.37M in cash and short term investments. This is sufficient to cover its annual cash burn of $29.65M.
  • There are more short-term assets than long-term liabilities on the EFTR balance sheet.

Negative Financial Indicators:

  • Total EFTR debt is still negative.
  • There are more short-term liabilities than short-term assets on the EFTR balance sheet.
  • EFTR has cash burn of 29647000. It does not have enough cash and short-term investments to cover this.
  • EFTR debt to equity ratio of -4.55 is negative.

Is it a good time to buy Effector Therapeutics stock, according to analysts?

Out of 1 Equities analysts who track EFTR, the consensus analyst rating on Effector Therapeutics is a Buy

Please note that analyst forecasts are not stock recommendations, nor are they financial advice.

You can dig deeper into what analysts are forecasting on the Effector Therapeutics stock forecast page.

EFTR Trading Indicators

SMA10
2.12
SMA20
7.58
SMA50
10.44
SMA100
11.03
SMA200
13.6
MACD
-2.97
MACD Signal
-2.41
MACD Histogram
-0.56
RSI
26.67
Stochastic %K
0.6
Stochastic %D
0.68
StochRSI %K
0.59
StochRSI %D
0.71

EFTR Growth Numbers

Last year, EFTR revenue was $0.00. In the last 3 year, EFTR's revenue has gone up by -100% per year. This was slower than the Biotechnology industry average of 28.98%.

Find out more about EFTR's earnings and revenue performance here.

What are EFTR insiders up to?

Over the past year, executives and large shareholders at EFTR have sold more shares than they have bought.

Sr One Capital Management LLC, 10% Owner of EFTR, was the latest EFTR insider to sell. They sold $108,401.10 worth of EFTR stock on Nov 27, 2023.

Learn more about who owns EFTR shares here.

Can I get consistent income from EFTR stock?

No, Effector Therapeutics doesn't provide an income stream by paying out dividends.

Get opinions from other traders

One of the primary reasons eToro is our highest-rated brokerage is because of its social trading community.

Click below to see what other investors have to say.

Step 5: Place your EFTR trade

You have two main options:

  • Market order: A market order is an order to buy or sell a stock at the best price on the market.
    Market orders are mostly the best for newer investors.
  • Limit order: A limit order enables you to buy or sell a security at a specific price (or better).
    If you want to ensure you're buying or selling at a given price, place a limit order.

Press the Open button and your broker will execute your order.

If you require additional help buying stocks on eToro, click the helpful video below:

Open eToro Account

Step 6: Watch your EFTR position

Now that you own some shares in EFTR, you'll want to stay up-to-date on your company.

Start a watchlist to keep tabs on your EFTR stock.

EFTR Feed

How to Buy Stock in Effector Therapeutics

To reiterate, here are the 6 steps for buying Effector Therapeutics stock:

  1. Choose where to buy Effector Therapeutics stock
  2. Open a brokerage account
  3. Deposit money your brokerage account
  4. Analyze Effector Therapeutics stock
  5. Place your EFTR trade
  6. Watch your EFTR position

If you need a brokerage account, eToro is our recommended venue.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

If you want to get notifications regarding your investment in Effector Therapeutics, hit the button below to create your watchlist.

NASDAQ: EFTR
$1.78-0.11 (-5.82%)
Updated Apr 18, 2024
Open eToro Account
NASDAQ: EFTR
$1.78-0.11 (-5.82%)
Updated Apr 18, 2024
Open eToro Account

FAQ

How much does it cost to buy one Effector Therapeutics share?

As of Apr 18, 2024, it costs $1.78 to buy one share of Effector Therapeutics stock.

Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $0.89, you can buy 0.5 shares of EFTR.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Is now a good time to buy Effector Therapeutics stock?

According to 1 Wall Street analysts who monitor Effector Therapeutics, their consensus recommendation is to buy Effector Therapeutics stock.

What is the best way to buy Effector Therapeutics stock?

One way to place an order for Effector Therapeutics stock is with a brokerage account.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.